Lavaca Capital’s Thermo Fisher Scientific TMO Stock Holding History

Lavaca Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$97.3K	Hold	194	–	–	0.01%	153
2026 Q1	$95.2K	Buy	194 +1	+0.5%	+$543	0.02%	130
2025 Q4	$112K	Buy	+193	New	+$109K	0.02%	125
2023 Q4	–	Sell	-3,873	Closed	-$1.96M	–	130
2023 Q3	$1.96M	Buy	3,873 +1,672	+76%	+$891K	0.66%	30
2023 Q2	$1.15M	Sell	2,201 -19	-0.9%	-$10.3K	0.34%	57
2023 Q1	$1.28M	Buy	2,220 +151	+7%	+$85.1K	0.27%	63
2022 Q4	$1.14M	Buy	+2,069	New	+$1.1M	0.36%	60
2019 Q2	–	Sell	-781	Closed	-$214K	–	327
2019 Q1	$214K	Buy	781 +762	+4,011%	+$190K	0.18%	67
2018 Q4	$4K	Buy	+19	New	+$4.46K	﹤0.01%	308

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Lavaca Capital's TMO Position: Q2 2026 in Review

Lavaca Capital held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 194 shares worth $97.3K. The position accounts for 0.01% of the portfolio, ranked #153.

Lavaca Capital first reported a position in TMO in Q4 2018 and has held it in 9 quarters since. The position peaked at $1.96M in Q3 2023. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Lavaca Capital held 194 shares of Thermo Fisher Scientific worth $97.3K as of Q2 2026.
Lavaca Capital left its Thermo Fisher Scientific share count unchanged in Q2 2026.
Thermo Fisher Scientific made up 0.01% of Lavaca Capital's portfolio in Q2 2026, its #153 holding.
Lavaca Capital first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 9 quarters since.
Lavaca Capital's Thermo Fisher Scientific position peaked at $1.96M in Q3 2023.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Lavaca Capital's 13F filing for Q2 2026, filed 14 Aug 2026.